Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2012 2
2014 1
2016 1
2017 2
2018 1
2019 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Carbon-ion radiation therapy for prostate cancer.
Ishikawa H, Tsuji H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Tsujii H; Working Group for Genitourinary Tumors. Ishikawa H, et al. Int J Urol. 2012 Apr;19(4):296-305. doi: 10.1111/j.1442-2042.2012.02961.x. Epub 2012 Feb 9. Int J Urol. 2012. PMID: 22320843 Review.
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Hayashi K, Ebner DK, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors. Kasuya G, et al. Oncotarget. 2019 Jan 1;10(1):76-81. doi: 10.18632/oncotarget.26539. eCollection 2019 Jan 1. Oncotarget. 2019. PMID: 30713604 Free PMC article.
Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Ebner DK, Hayashi K, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors. Kasuya G, et al. Cancer Sci. 2018 Sep;109(9):2873-2880. doi: 10.1111/cas.13727. Epub 2018 Sep 1. Cancer Sci. 2018. PMID: 29981249 Free PMC article.
Hypofractionated radiotherapy with carbon ion beams for prostate cancer.
Tsuji H, Yanagi T, Ishikawa H, Kamada T, Mizoe JE, Kanai T, Morita S, Tsujii H; Working Group for Genitourinary Tumors. Tsuji H, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1153-60. doi: 10.1016/j.ijrobp.2005.04.022. Epub 2005 Jun 28. Int J Radiat Oncol Biol Phys. 2005. PMID: 15990247 Clinical Trial.
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G, Ishikawa H, Tsuji H, Nomiya T, Makishima H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Haruyama Y, Kobashi G, Tsujii H; Working Group for Genitourinary Tumors. Kasuya G, et al. Cancer. 2016 Oct 15;122(20):3225-3231. doi: 10.1002/cncr.30050. Epub 2016 Jun 28. Cancer. 2016. PMID: 27351298 Free PMC article. Clinical Trial.
Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
Kasuya G, Ishikawa H, Tsuji H, Haruyama Y, Kobashi G, Ebner DK, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Makishima H, Nomiya T, Kamada T, Tsujii H; Working Group for Genitourinary Tumors. Kasuya G, et al. Cancer Sci. 2017 Dec;108(12):2422-2429. doi: 10.1111/cas.13402. Epub 2017 Nov 3. Cancer Sci. 2017. PMID: 28921785 Free PMC article.
12 results